What You Should Know:
– ALIGNMT AI, a leading platform for AI governance and risk monitoring, announced today a collaboration through the MSK Innovation Hub (iHub) at Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading cancer treatment and research institutions.
– The relationship will leverage ALIGNMT’s Governance Platform to enhance operationalization of key aspects of MSK’s responsible oncology AI governance processes.
ALIGNMT AI and MSK iHub Partner to Advance Responsible AI Governance in Healthcare
ALIGNMT AI delivers end-to-end AI governance and risk management solutions designed to protect artificial intelligence across its full lifecycle. The platform integrates automated compliance workflows, continuous risk monitoring, and transparency reporting into a single scalable system—replacing fragmented oversight with unified, efficient processes. Certified by the Coalition for Healthcare AI and trusted by leading healthcare organizations, ALIGNMT AI enables responsible AI deployment without compromising operational performance or patient safety.
The collaboration with MSK iHub underscores the urgent need for robust AI oversight in healthcare. Institutions such as Memorial Sloan Kettering (MSK) face rising regulatory requirements and increasing pressure to safeguard patients as AI adoption accelerates. By working together, ALIGNMT AI and MSK iHub aim to establish a scalable framework for responsible AI governance that can serve as a model for the broader industry.
“Healthcare leaders are recognizing that AI governance is no longer optional—it’s critical infrastructure that must integrate seamlessly with production workflows to enable real-time risk monitoring,” said Andreea Bodnari, CEO of ALIGNMT AI. “Through the MSK iHub program, we can refine, scale, and further advance ALIGNMT’s governance solutions to better serve the healthcare sector.”
